Dec 11, 2025 · Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated …

Dec 22, 2025 · A detailed overview of Illumina, Inc. (ILMN) stock, including real-time price, chart, key statistics, news, and more.

Dec 26, 2025 · Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.

We are Illumina We are a global genomics and human health leader innovating the future of precision health. We develop DNA sequencing and array-based life sciences technologies to …

1 day ago · Here’s who holds the biggest stakes in Illumina today and what recent ownership and insider activity suggest about confidence in its long-term growth outlook.

2 days ago · Illumina Q3 earnings beat estimates, prompting Cwm LLC to boost its stake by 43.9%. Discover why analysts maintain a 'Hold' rating despite strong results.

5 days ago · Cwm LLC lifted its position in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 43.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange …

Illumina offers a broad range of sequencing and microarray products for diverse genomic analysis applications.

A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, …